These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 367306)
21. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients. Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965 [TBL] [Abstract][Full Text] [Related]
22. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients. Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918 [TBL] [Abstract][Full Text] [Related]
23. Renal transplantation and viral infections. II. Results of follow-up studies. Huraux JM; Bricout F; Nicolas JC; Regnard J; Bogossian M; Descamps P; Grimfeld A; Gerbal A; Baptista-Lourenco MH Biomedicine; 1975 Jul; 22(4):311-9. PubMed ID: 179630 [TBL] [Abstract][Full Text] [Related]
24. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
25. Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection. Lordon RE; Wilson RL; Shield CF; Ferrone S Transplantation; 1981 Oct; 32(4):286-90. PubMed ID: 7036445 [TBL] [Abstract][Full Text] [Related]
26. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients. Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608 [TBL] [Abstract][Full Text] [Related]
27. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development. Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI Clin Transpl; 2006; ():241-53. PubMed ID: 18365382 [TBL] [Abstract][Full Text] [Related]
28. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation. Manga Sahin G; Sahin S; Kantarci G; Ergin H Transplant Proc; 2006 Mar; 38(2):499-501. PubMed ID: 16549159 [TBL] [Abstract][Full Text] [Related]
29. Histological analysis of late renal allografts of antidonor antibody positive patients with C4d deposits in peritubular capillaries. Aita K; Yamaguchi Y; Shimizu T; Horita S; Furusawa M; Tanabe K; Fuchinoue S; Toma H Clin Transplant; 2004; 18 Suppl 11():7-12. PubMed ID: 15191366 [TBL] [Abstract][Full Text] [Related]
30. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay. Cadillo-Chávez R; de Echegaray S; Santiago-Delpín EA; Rodríguez-Trinidad AT; Camacho-Carrazo B; Alfaro T; Saavedra-Pozo M; Carrasquillo L; González-Caraballo ZA; Morales-Otero LA Transplant Proc; 2006 Apr; 38(3):918-20. PubMed ID: 16647510 [TBL] [Abstract][Full Text] [Related]
31. Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. Fiala M; Payne JE; Berne TV; Moore TC; Henle W; Montgomerie JZ; Chatterjee SN; Guze LB J Infect Dis; 1975 Oct; 132(4):421-33. PubMed ID: 171315 [TBL] [Abstract][Full Text] [Related]
32. Transplant survival and antibody to hepatitis virus. Cuthbert J; Ware A; Combes B; Mauk R; Hull A N Engl J Med; 1977 Nov; 297(19):1068. PubMed ID: 333289 [No Abstract] [Full Text] [Related]
33. Etiology of liver disease in renal-transplant patients. Ware AJ; Luby JP; Hollinger B; Eigenbrodt EH; Cuthbert JA; Atkins CR; Shorey J; Hull AR; Combes B Ann Intern Med; 1979 Sep; 91(3):364-71. PubMed ID: 224742 [TBL] [Abstract][Full Text] [Related]
34. Viral infection and renal transplant rejection. Briggs JD; Timbury MC; Paton AM; Bell PR Br Med J; 1972 Dec; 4(5839):520-2. PubMed ID: 4566016 [TBL] [Abstract][Full Text] [Related]
35. Renal transplantation and viral infections. I. A retrospective serological study of renal transplantation recipients. Huraux JM; Bricout F; Idatte JM; Leroux-Robert C; Regnard J; Lagrange P; Kourilsky O; Acar J Rev Eur Etud Clin Biol; 1972; 17(7):670-9. PubMed ID: 4346547 [No Abstract] [Full Text] [Related]
36. Rubella antibodies and adverse events late after renal transplantation. Luby JP; Ware AJ; Vergne-Marini P; Stastny P; Hull AR Arch Intern Med; 1979 Jan; 139(1):33-5. PubMed ID: 367306 [TBL] [Abstract][Full Text] [Related]
37. Disease due to cytomegalovirus and its long-term consequences in renal transplant recipients. Correlation of allograft survival with disease due to cytomegalovirus and rubella antibody level. Luby JP; Ware AJ; Hull AR; Helderman JH; Gailiunas P; Butler S; Atkins C Arch Intern Med; 1983 Jun; 143(6):1126-9. PubMed ID: 6305295 [TBL] [Abstract][Full Text] [Related]
38. Rubella antibodies in women of childbearing age during an epidemic and the two years thereafter. Hornstein L; Ben-Porath E Isr J Med Sci; 1976 Oct; 12(10):1189-93. PubMed ID: 990135 [TBL] [Abstract][Full Text] [Related]
39. [Hepatitis B virus, serological markers of viral infections and humoral immunity in alcoholic cirrhosis]. Vetter D; Doffoël M; Gut JP; Doffoël S; North ML; Charrault A; Ventre G; Mayer S; Bockel R Gastroenterol Clin Biol; 1985 May; 9(5):389-95. PubMed ID: 2989068 [TBL] [Abstract][Full Text] [Related]